U
StemGen, Inc.
SGNI
$0.10
$0.06150.00%
D
Sell
11/16/2022Upgraded
StemGen, Inc. (SGNI) was upgraded to D- from E+ on 11/16/2022 due to an increase in the volatility index.
StemGen, Inc. (SGNI) was upgraded to D- from E+ on 11/16/2022 due to an increase in the volatility index.
E
Sell
8/10/2022Downgrade
StemGen, Inc. (SGNI) was downgraded to E+ from D- on 8/10/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 325.19% from -$40.5 to -$172.2, operating cash flow declined 256.68% from -$40.4 to -$144.1, and earnings per share declined from -$0.0018 to -$0.0041.
StemGen, Inc. (SGNI) was downgraded to E+ from D- on 8/10/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 325.19% from -$40.5 to -$172.2, operating cash flow declined 256.68% from -$40.4 to -$144.1, and earnings per share declined from -$0.0018 to -$0.0041.
D
Sell
7/25/2022Downgrade
StemGen, Inc. (SGNI) was downgraded to D- from D on 7/25/2022 due to a significant decline in the total return index and volatility index.
StemGen, Inc. (SGNI) was downgraded to D- from D on 7/25/2022 due to a significant decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
StemGen, Inc. (SGNI) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index.
StemGen, Inc. (SGNI) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index.
D
Sell
4/20/2022Downgrade
StemGen, Inc. (SGNI) was downgraded to D- from D on 4/20/2022 due to a decline in the volatility index.
StemGen, Inc. (SGNI) was downgraded to D- from D on 4/20/2022 due to a decline in the volatility index.
D
Sell
11/3/2021Upgraded
StemGen, Inc. (SGNI) was upgraded to D from D- on 11/3/2021 due to a large increase in the solvency index and total return index.
StemGen, Inc. (SGNI) was upgraded to D from D- on 11/3/2021 due to a large increase in the solvency index and total return index.
D
Sell
10/18/2021Downgrade
StemGen, Inc. (SGNI) was downgraded to D- from D on 10/18/2021 due to a substantial decline in the growth index and solvency index. The quick ratio declined from 0.01 to 0, EBIT declined 61.43% from -$57.3 to -$92.5, and earnings per share declined from -$0.0022 to -$0.0034.
StemGen, Inc. (SGNI) was downgraded to D- from D on 10/18/2021 due to a substantial decline in the growth index and solvency index. The quick ratio declined from 0.01 to 0, EBIT declined 61.43% from -$57.3 to -$92.5, and earnings per share declined from -$0.0022 to -$0.0034.
D
Sell
11/18/2020Upgraded
StemGen, Inc. (SGNI) was upgraded to D from D- on 11/18/2020 due to a noticeable increase in the volatility index, growth index and total return index. Total revenue increased 36.36% from $17.6 to $24.
StemGen, Inc. (SGNI) was upgraded to D from D- on 11/18/2020 due to a noticeable increase in the volatility index, growth index and total return index. Total revenue increased 36.36% from $17.6 to $24.
D
Sell
7/29/2020Downgrade
StemGen, Inc. (SGNI) was downgraded to D- from D on 7/29/2020 due to a decline in the volatility index and total return index.
StemGen, Inc. (SGNI) was downgraded to D- from D on 7/29/2020 due to a decline in the volatility index and total return index.
D
Sell
6/11/2020Upgraded
StemGen, Inc. (SGNI) was upgraded to D from D- on 6/11/2020 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 237.18% from -$7.8 to $10.7, EBIT increased 43.27% from -$20.8 to -$11.8, and earnings per share increased from -$0.0014 to -$0.0012.
StemGen, Inc. (SGNI) was upgraded to D from D- on 6/11/2020 due to an increase in the total return index, growth index and volatility index. Operating cash flow increased 237.18% from -$7.8 to $10.7, EBIT increased 43.27% from -$20.8 to -$11.8, and earnings per share increased from -$0.0014 to -$0.0012.
D
Sell
5/1/2020Downgrade
StemGen, Inc. (SGNI) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index and solvency index.
StemGen, Inc. (SGNI) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index and solvency index.
D
Sell
4/1/2020Upgraded
StemGen, Inc. (SGNI) was upgraded to D from D- on 04/01/2020.
StemGen, Inc. (SGNI) was upgraded to D from D- on 04/01/2020.
D
Sell
12/2/2019Upgraded
StemGen, Inc. (SGNI) was upgraded to D- from E on 12/2/2019 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 376.19% from $2.1 to $10, and earnings per share increased from -$0.006 to -$0.0022.
StemGen, Inc. (SGNI) was upgraded to D- from E on 12/2/2019 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 376.19% from $2.1 to $10, and earnings per share increased from -$0.006 to -$0.0022.
E
Sell
9/3/2019Upgraded
StemGen, Inc. (SGNI) was upgraded to E from E- on 9/3/2019 due to an increase in the total return index.
StemGen, Inc. (SGNI) was upgraded to E from E- on 9/3/2019 due to an increase in the total return index.
E
Sell
6/24/2019None
StemGen, Inc. (SGNI) was downgraded to E- from U on 06/24/2019.
StemGen, Inc. (SGNI) was downgraded to E- from U on 06/24/2019.
OTC PK
08/26/2022 3:04PM Eastern
Quotes delayed
